Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High mortality during direct acting antiviral therapy for hepatitis C patients with Child's C cirrhosis: Results of the Irish Early Access Programme.
Gray E, O'Leary A, Stewart S, Bergin C, Cannon M, Courtney G, Crosbie O, De Gascun CF, Fanning LJ, Feeney E, Houlihan DD, Kelleher B, Lambert JS, Lee J, Mallon P, McConkey S, McCormick A, McKiernan S, McNally C, Murray F, Sheehan G, Norris S; Irish Hepatitis C Outcomes and Research Network (ICORN). Gray E, et al. Among authors: de gascun cf. J Hepatol. 2016 Aug;65(2):446-8. doi: 10.1016/j.jhep.2016.03.022. Epub 2016 Apr 27. J Hepatol. 2016. PMID: 27130842 No abstract available.
Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access program.
Gray E, O'Leary A, Bergin C, Cannon M, Courtney G, Crosbie O, De Gascun CF, Fanning LJ, Feeney E, Houlihan DD, Kelleher B, Lambert JS, Lee J, Mallon P, McConkey S, McCormick A, McKiernan S, McNally C, Murray F, Sheehan G, Stewart S, Walsh C, Norris S; Irish Hepatitis C Outcomes and Research Network (ICORN). Gray E, et al. Among authors: de gascun cf. Expert Rev Gastroenterol Hepatol. 2017 Jun;11(6):593-601. doi: 10.1080/17474124.2017.1292850. Epub 2017 Feb 22. Expert Rev Gastroenterol Hepatol. 2017. PMID: 28276815
The duration of infectiousness of individuals infected with SARS-CoV-2.
Walsh KA, Spillane S, Comber L, Cardwell K, Harrington P, Connell J, Teljeur C, Broderick N, de Gascun CF, Smith SM, Ryan M, O'Neill M. Walsh KA, et al. Among authors: de gascun cf. J Infect. 2020 Dec;81(6):847-856. doi: 10.1016/j.jinf.2020.10.009. Epub 2020 Oct 10. J Infect. 2020. PMID: 33049331 Free PMC article. Review.
Alternative clinical specimens for the detection of SARS-CoV-2: A rapid review.
Comber L, Walsh KA, Jordan K, O'Brien KK, Clyne B, Teljeur C, Drummond L, Carty PG, De Gascun CF, Smith SM, Harrington P, Ryan M, O'Neill M. Comber L, et al. Among authors: de gascun cf. Rev Med Virol. 2021 Jul;31(4):e2185. doi: 10.1002/rmv.2185. Epub 2020 Oct 22. Rev Med Virol. 2021. PMID: 33091200 Review.
Airborne transmission of SARS-CoV-2 via aerosols.
Comber L, O Murchu E, Drummond L, Carty PG, Walsh KA, De Gascun CF, Connolly MA, Smith SM, O'Neill M, Ryan M, Harrington P. Comber L, et al. Among authors: de gascun cf. Rev Med Virol. 2021 May;31(3):e2184. doi: 10.1002/rmv.2184. Epub 2020 Oct 26. Rev Med Virol. 2021. PMID: 33105071 Free PMC article.
Quantifying the risk of SARS-CoV-2 reinfection over time.
O Murchu E, Byrne P, Carty PG, De Gascun C, Keogan M, O'Neill M, Harrington P, Ryan M. O Murchu E, et al. Rev Med Virol. 2022 Jan;32(1):e2260. doi: 10.1002/rmv.2260. Epub 2021 May 27. Rev Med Virol. 2022. PMID: 34043841 Free PMC article. Review.
111 results